NT_1170x120_1-11-18

Dr. Reddy’s releases store-brand version of Xyzal Allergy 24HR

Print Friendly, PDF & Email
PRINCETON, N.J. — Dr. Reddy’s Laboratories has launched levocetirizine dihydrochloride tablets 5 mg, an over-the-counter allergy medication, in the U.S. market.

Dr. Reddy’s said its levocetirizine dihydrochloride tablets are a generic version of Xyzal Allergy 24HR Tablets from Chattem-Sanofi. The 5-mg Dr. Reddy’s product comes in various consumer-oriented package sizes.

“This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” stated Milan Kalawadia, vice president and head of U.S. over-the-counter and specialty Rx businesses at Dr. Reddy’s. “We look forward to collaborating with our customers to bring high-quality, affordable store-brand alternatives to the market.”

An antihistamine, levocetirizine dihydrochloride tablets (5 mg) are indicated for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes and nose, and sneezing.

Xyzal Allergy 24HR Tablets had U.S. sales of approximately $71 million for the 12 months through January 2018, according to IRI market data reported by Dr. Reddy’s.


EMC_728x90

FREUD_728x90_6-19-20

Comments are closed.